• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chinook Therapeutics Inc (NQ: KDNY )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Chinook Therapeutics Inc

    < Previous 1 2 3 4 Next >
    Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
    Via Benzinga
    Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Chinook Therapeutics Inc. (NASDAQ: KDNY) Highlighted for Surprising Price Action
    Via Investor Brand Network
    Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
    Via Benzinga
    Expert Ratings for Chinook Therapeutics
    Via Benzinga
    Bragar Eagel & Squire, P.C. Is Investigating JinkoSolar, Integra, Chinook, and Comerica and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Chinook Therapeutics Inc. (NASDAQ: KDNY) Near the Top of Equities by Percentage Gain on 6/12
    Via Investor Brand Network
    Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Bragar Eagel & Squire, P.C. Is Investigating Chinook, Comerica, Advance Auto Parts, and EPAM and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, DLocal, and Comerica and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
    Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis. 
    Via Investor's Business Daily
    Bragar Eagel & Squire, P.C. Is Investigating Chinook, DLocal, Comerica, and Advanced Auto Parts and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Bowlero, Integra, Chinook, and DLocal and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Why Shares of Vera Therapeutics Jumped Tuesday
    The company announced early phase 2 trials information regarding its lead therapy. 
    Via The Motley Fool
    2 Surging Healthcare Stocks With More Fuel in the Tank
    These stocks climbed 74% and 78% over the past month and there could be more gains ahead. 
    Via The Motley Fool
    Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, Phathom, and Akumin and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
    Stocks kept powering higher despite, but the Nasdaq is looking extended. 
    Via Investor's Business Daily
    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: NexTier Oilfield Solutions Inc. (NYSE – NEX), Chinook Therapeutics, Inc. (Nasdaq – KDNY), Franchise Group, Inc. (Nasdaq – FRG), Greenhill & Co., Inc. (NYSE – GHL)
    From Brodsky & Smith LLC
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Is Investigating Integra, Chinook, and DZS and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
    Via Benzinga
    CHINOOK THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chinook Therapeutics, Inc. - KDNY
    From Kahn Swick & Foti, LLC
    Via Business Wire
    Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
    Via Benzinga
    Novartis Stock Screams Value After Chinook Therapeutics Buyout
    Following a buyout of Chinook Therapeutics, Novartis slipped less than 1%. This speaks to the growth potential of Chinook and ongoing value of Novartis stock. 
    Via MarketBeat
    KDNY Stock Alert: Why Short Seller Muddy Waters Is Betting Against Chinook
    Chinook Therapeutics is about to be acquired by Novartis. News of this deal hasn't stopped Muddy Waters from betting against KDNY stock. 
    Via InvestorPlace
    Nasdaq Gains 1%; US Budget Deficit Widens In May
    U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500,... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.